Average Co-Inventor Count = 4.74
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (5 from 1,149 patents)
2. Cenes Limited (5 from 11 patents)
3. Glaxosmithkline Intellectual Property (no.2) Limited (3 from 92 patents)
4. Smithkline Beecham Corporation (2 from 2,198 patents)
5. Glaxosmithkline LLC (2 from 356 patents)
6. Glaxo Group Limited (1 from 1,168 patents)
7. Glaxo Wellcome Inc. (1 from 281 patents)
19 patents:
1. 11001556 - Crystalline forms
2. 10562852 - Crystalline forms of (R)-1-(1-(methylsulfonyl)propan-2-yl)-4-(trifluoromethyl)-1H-indole-5-carbonitrile
3. 9902694 - Crystalline forms
4. 8455497 - Inhibitors of aspartyl protease
5. 7834063 - Benzonitryl and nitrobenzyl derivatives that modulate androgen receptors
6. 7723385 - Aniline derivatives as selective androgen receptor modulators
7. 7592368 - Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
8. 7528127 - Short-acting benzodiazepines
9. 7514470 - Aniline derivatives as selective androgen receptor modulators
10. 7485635 - Short-acting benzodiazepines
11. 7473689 - Short-acting benzodiazepines
12. 7435730 - Short-acting benzodiazepines
13. 7195752 - Surfactant compounds and uses thereof
14. 7173134 - Selective RXR ligands
15. 7160880 - Short-acting benzodiazepines